AFENET COVID-19 at a Glance # 125

Published on March 3, 2021

AFENET COVID-19 at a Glance Issue # 125 is now available

Other news

Turkish study revises down Sinovac COVID-19 vaccine efficacy to 83.5%

March 3, 2021
The COVID-19 vaccine developed by China’s Sinovac Biotech has an efficacy of 83.5% based on final results of Phase III trials, Turkish researchers said on Wednesday, a downward revision from a preliminary finding of 91.25%. Reuters

EARLY RELEASE: First Identified Cases of SARS-CoV-2 Variant P.1 in the United States - Minnesota, January 2021

March 3, 2021
This report describes the first two U.S. cases of the SARS-CoV-2 variant P.1, which were identified in Minnesota.